Went over the latest IBD and it looks like the healthcare has advanced according to IBD, however I am not willing to take it at strictly face value which I will explain. This week there is 11 healthcare-related industries within the top 25 a whopping 44% representation and they are:
#2 Medical/Dental-Services
#3 Medical-Ethical Drugs
#5 Medical-Genetics
#6 Medical-Systems/Equipment
#12 Medical-Health Maintenance Organizations
#13 Medical-Products
#15 Medical-Wholesale Drug/Supply
#16 Medical-Drug/Diversified
#17 Medical-Outpatient/Home Care
#18 Medical-Biomed/Biotech
#24 Medical-Generic/Drugs
This sounds and looks great on the surface, however here is my concern. I sometimes use the IBD 100 to help focus on some momentum stocks and have a set of criteria I follow with regards to overall stock rank and group ranking. Normally, I will have my steady performers who are always on the list in one form or another i.e. POT, ISRG, VIP etc...However this week there was a tremendous amount of new companies into my numbers on the order of +35%, which is not normal. I find during volatile times some companies make a big move one week, so they find themselves into my numbers, but drop out shortly thereafter.
So you may ask...How does this all tie into healthcare? Well, 8 of the 20 new entries are related to the healthcare industry, so I am a bit hesitant and have a gut feeling that there may be more "pain" to follow. Here are those new entries
1. Yamana Gold INC (
AUY)
2. Blackrock (
BLK)
3. American Public Education INC (
APEI)
4. Omnicell (
OMCL) (I do own shares of this company)
5. Flir Systems INC (
FLIR)
6. Amedisys (
AMED)
7. Energen (
EGN)
8. Strayer Education (
STRA)
9. Invitrogen (
IVGN)
10. Icon Plc ADS (
ICLR)
11. Covance (
CVD)
12. Mechel Oao ADS (
MTL)
13. Stericycle (
SRCL)
14. Genzyme Corp (
GENZ)
15. Berkshire Hathaway A (
BRKA)
16. Kendle Intl (
KNDL)
17. Apollo Group A (
APOL)
18. Cellcom Israel Ltd (
CEL)
19. Axsys Tech (
AXYS)
20. Continental Res INC (
CLR)